Gene · 1942
Papers1,708
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,708
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of WIF-1 in regulating chondrocyte dedifferentiation and matrix production through WNT pathway. | Regen Ther | 2026 | 41809618 | PubTator, text mining | PubMed |
| Integrative omics and experimental validation reveal METTL17 and SLC27A1 as biomarkers and potential therapeutic targets in chronic kidney disease. | Front Immunol | 2026 | 41766913 | PubTator, text mining | PubMed |
| Somatic structural variants drive upper tract urothelial carcinoma muscle invasiveness via activation of TPX2 transcription. | EBioMedicine | 2026 | 41740229 | PubTator, text mining | PubMed |
| Identification of ephrin-A1-EphA2 signalling as a potential target for fracture prevention. | Nat Commun | 2026 | 41723149 | PubTator, text mining | PubMed |
| Inference of Genetic Networks from Pseudo Time Series of Single-cell Gene Expression Data using Modified Random Forests. | Bull Math Biol | 2026 | 41721174 | PubTator, text mining | PubMed |
| Role and underlying mechanisms of miR‑200 family in breast cancer (Review). | Int J Oncol | 2026 | 41716019 | PubTator, text mining | PubMed |
| Current Insights and Future Directions of Multiomic and Spatial-Omic Analysis in Non-Small Cell Lung Cancer. | JCO Precis Oncol | 2026 | 41712875 | PubTator, text mining | PubMed |
| The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors. | Biochem Pharmacol | 2026 | 41692350 | PubTator, text mining | PubMed |
| Cross-ancestry genome-wide association studies of liver function biomarkers uncover pleiotropic variants, systemic disease links and therapeutic targets. | Genome Med | 2026 | 41689074 | PubTator, text mining | PubMed |
| Integrating plasma proteomes with genome-wide association data for causal protein identification in hepatocellular carcinoma: A bidirectional Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41578465 | PubTator, text mining | PubMed |
| Free-floating long-term vascularized mesenchymal organoids. | iScience | 2026 | 41568151 | PubTator, text mining | PubMed |
| Integrative Multiscale Analysis Reveals EFNA1-Driven Immune Remodeling Promotes Colorectal Cancer Lymph Node Metastasis. | Hum Mutat | 2026 | 41542227 | PubTator, text mining | PubMed |
| SiMPull-POP: Quantification of Membrane Protein Assembly via Single Molecule Photobleaching. | Bio Protoc | 2026 | 41523099 | PubTator, text mining | PubMed |
| Transcriptome of the human C2 dorsal root ganglia in C1-2 arthrodesis surgery: insight for neck pain. | Brain | 2026 | 41032656 | PubTator, text mining | PubMed |
| Monocyte/macrophage-derived IL-15 activates STAT5 to trigger the EFNA1/NCOA2-positive feedback loop, facilitating retinal angiogenesis in high-glucose environments. | Mol Vis | 2025 | 41867368 | PubTator, text mining | PubMed |
| Ephrin Receptors and Ephrin Ligands in Uveal Melanoma: A Big Data Analysis Using Web Resources. | Int J Mol Sci | 2025 | 41516312 | PubTator, text mining | PubMed |
| Beyond cell-cell contact: therapeutic potential of Eph signaling in central nervous system tumors. | Front Mol Neurosci | 2025 | 41200151 | PubTator, text mining | PubMed |
| Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication. | Biochem Pharmacol | 2025 | 41047040 | PubTator, text mining | PubMed |
| Structural Role of Conformational Heterogeneity and Juxtamembrane Regions in the Ephrin A1 Interactions With the EphA2 Receptor Ligand-binding Domain. | J Mol Biol | 2025 | 40998111 | PubTator, text mining | PubMed |
| Novel insights into the relationship between glaucoma and brain diseases from the genetic to diseases levels: A cross-sectional study. | Medicine (Baltimore) | 2025 | 40988281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1942/papers?page=2